Company: MIRA
Filing Date: 2025-04-15
Form Type: 10-K/A
Source: 0001641172-25-004871
Chunk: 0

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-04-15
Form: 10-K/A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K/A

Amendment No.1</div>

| ☒ | ANNUAL                                                                        
 REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |

<div align='center'>For the fiscal year ended December 31, 2024</div>

| ☐ | TRANSITION                                                                    
 REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |

<div align='center'>For the transition period from ________to_________

Commission file number 001-31361

MIRA Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)</div>

| Florida                                           |     |     85-3354547 |
| (State                                            
 or other jurisdiction of                          
 incorporation                                     
 or organization)                                  |     |        -I.R.S. 
       Employer 
 Identification 
            No. |
| 1200                                              
 Brickell Avenue, Suite 1950 #1183, Miami, Florida |     |          33131 |
| (Address                                          
 of principal executive offices)                   |     |           -Zip 
           Code |

<div align='center'>Registrant’s telephone number, including area code: 786- 432-9792</div>

Securities registered pursuant to Section 12(b) of the Act:

| Title                    
 of each class            |     | Trading   
 Symbol(s) |     | Name                            
 of exchange on which registered |
| Common                   
 stock, par value $0.0001 |     | MIRA      |     | The                             
 Nasdaq Capital Market           |

<div align='center'>Securities registered pursuant to Section 12(g) of the Act: None</div>

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes ☐ No☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period